Literature DB >> 15070711

The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome.

Hideo Harigae, Gang Xu, Tomohiro Sugawara, Izumi Ishikawa, Tsutomu Toki, Etsuro Ito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15070711     DOI： 10.1182/blood-2004-01-0016

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  Transient abnormal myelopoiesis in a cytogenetically normal neonate.

Authors:  Kentaro Yanase; Keisuke Kato; Nobuko Katayama; Yoko Mouri; Chie Kobayashi; Junko Shiono; Masakazu Abe; Ai Yoshimi; Kazutoshi Koike; Jun-Ichi Arai; Masahiro Tsuchida
Journal:  Int J Hematol       Date:  2010-09-23       Impact factor: 2.490

Review 2.  GATA transcription factors in hematologic disease.

Authors:  Alan B Cantor
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

3.  The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor.

Authors:  Barbara Ghinassi; Massimo Sanchez; Fabrizio Martelli; Giovanni Amabile; Alessandro Maria Vannucchi; Giovanni Migliaccio; Stuart H Orkin; Anna Rita Migliaccio
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

4.  Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.

Authors:  Yubin Ge; Alan A Dombkowski; Katherine M LaFiura; Dana Tatman; Ravikiran S Yedidi; Mark L Stout; Steven A Buck; Gita Massey; David L Becton; Howard J Weinstein; Yaddanapudi Ravindranath; Larry H Matherly; Jeffrey W Taub
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

5.  Two Novel GATA1 Mutations in Transient Abnormal Myelopoiesis of Thai Neonates with Down Syndrome.

Authors:  Kanokporn Chukua; Chayanont Netsawang; Kittipoom Padungthai; Thanitchet Khetkham; Piyaporn Chokevittaya; Onapinya Poonjearansilp; Sariya Prachuktum; Sudatip Kositamongkol; Wiliporn Techasatit; Phakatip Silapamongkolkul; Wallee Satayasai; Tasama Pusongchai; Pacharapan Surapolchai; Kitiwan Rojnueangnit
Journal:  J Pediatr Genet       Date:  2019-09-11

6.  Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis.

Authors:  Alessandro M Vannucchi; Alessandro Pancrazzi; Paola Guglielmelli; Simonetta Di Lollo; Costanza Bogani; Gianna Baroni; Lucia Bianchi; Anna Rita Migliaccio; Alberto Bosi; Francesco Paoletti
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

Review 7.  Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection.

Authors:  Nikolaos Papadantonakis; Shinobu Matsuura; Katya Ravid
Journal:  Blood       Date:  2012-07-05       Impact factor: 22.113

8.  GATA Transcription Factors and Cancer.

Authors:  Rena Zheng; Gerd A Blobel
Journal:  Genes Cancer       Date:  2010-12

9.  Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation.

Authors:  Andrew J Woo; Karen Wieland; Hui Huang; Thomas E Akie; Taylor Piers; Jonghwan Kim; Alan B Cantor
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

10.  Loss of Full-Length GATA1 Expression in Megakaryocytes Is a Sensitive and Specific Immunohistochemical Marker for the Diagnosis of Myeloid Proliferative Disorder Related to Down Syndrome.

Authors:  Winston Y Lee; Olga K Weinberg; Andrew G Evans; Geraldine S Pinkus
Journal:  Am J Clin Pathol       Date:  2018-03-07       Impact factor: 2.493
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.